The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Qiagen, a molecular diagnostics company, and spinoff company APIS Assay Technologies, the AHSN, academia and the NHS have created a long-term partnership that has brought investment and jobs to the Greater Manchester area. Access to new tests and targeted treatments developed through pioneering research will bring fast-tracked real health benefits to local residents, and ultimately people nationally and internationally.
The O2COMFORT flowmeter offers an innovative answer to oxygen therapy. This device can deliver oxygen in a traditional, continuous manner, but it also contains a comfort mode in which a dose of oxygen is only administered upon inhalation. The comfort settings 1 to 5 give an equivalent therapy of 1 to 5 litres per minute of continuous flow. The flowmeter offers additional advantages over the traditional flowmeter. When in comfort mode, the oxygen delivery follows the natural breath rate of the patient. In this way the O2COMFORT flowmeter increases the wellbeing of the patient while reducing the waste of medical oxygen.
